Compounds and methods of promoting oligodendrocyte precursor differentiation

Details for Australian Patent Application No. 2009313315 (hide)

Owner The Cleveland Clinic Foundation

Inventors Pedraza, Carlos E.; Macklin, Wendy B.; Muratova, Elena; Sokolov, Victor

Agent Fisher Adams Kelly

Pub. Number AU-A-2009313315

PCT Pub. Number WO2010/054307

Priority 61/112,449 07.11.08 US; 61/149,929 04.02.09 US

Filing date 9 November 2009

Wipo publication date 14 May 2010

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/18 (2006.01) - Sulfonamides

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/054307 Priority application(s): WO2010/054307

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313316-Hydrogel-filled drug delivery reservoirs

2009313307-Solid composition having enhanced physical and electrical properties